Dr. Cathy Eng
@CathyEngMD
Co-Director/Co-Leader GI Oncology Research; Exec Direc Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations
ID:1548726020
https://www.vanderbilthealth.com/cancer/ 26-06-2013 17:39:07
9,5K Tweets
11,1K Followers
4,0K Following
Follow People
LAST debate of Great Debates & Updates #NYC : Is REPEAT next generation sequencing needed in ALL mCRC patients at progression: Yes (@NVijayvergiaMD Fox Chase Cancer Center) vs. No (@pashtoonkasi Weill Cornell Medicine). What do you do in everyday practice?
#cancer #crcsm #colorectal #cancer research
Michael Lidsky, MD, FACS debating FOR the role of #HAI for treated #mCRC . Highlighting the multidisciplinary study of modern times ECOG-ACRIN Cancer Research Group #PUMP trial to settle the debate but Dr P Phillip is trying to answer it now Duke Cancer Henry Ford Health Dr. Cathy Eng Yelena Y. Janjigian MD
Cheers 🥂to Neil H. Segal MD PhD who has been redeemed as the winner of today's debate Great Debates & Updates for single agent IO given the lack of existing data re: Nivo/Ipi vs. Nivo (all data still pending) on CM8HW. More to follow! #cancer #immuotherapy #crcsm
This is another great topic Great Debates & Updates: Doublet (Dr. M. Overman MD Anderson Cancer Center) vs. single IO (@segaln MSKCC) therapy for met #colorectal #cancer MSI-H patients based on KN177 vs. Checkmate 142 or 8HW (early findings). Thoughts? #cancer research
Dr. Cathy Eng Great Debates & Updates MD Anderson Cancer Center Neil H. Segal MD PhD MSKCC Fascinating debate, Cathy! KN177 vs. Checkmate 142 offer pivotal insights for MSI-H colorectal cancer treatment. Thoughts on long-term efficacy? #cancerresearch
Great Debates & Updates day#2: got to sit in on the short course vs. long course neoadjuvant XRT in rectal cancer debate. Absolutely LOVED hearing both sides! Learned alot!! GI Cancers Alliance Cure GI Cancers Raymond Foundation
#cancerresearch #SCRT #LCRT #colorectalcancer #GDUGI
This is another great topic Great Debates & Updates: Doublet (Dr. M. Overman MD Anderson Cancer Center) vs. single IO (@segaln MSKCC) therapy for met #colorectal #cancer MSI-H patients based on KN177 vs. Checkmate 142 or 8HW (early findings). Thoughts? #cancer research
Wonderful to be Great Debates & Updates with Dr. Cathy Eng and Yelena Y. Janjigian MD debating the eloquent Dr Diedre Cohen!
Great Debates & Updates Day#1:
When some of your favorite #oncologists stop by your exhibiting booth, you have to take photos!! GI Cancers Alliance Cure GI Cancers
Raymond Foundation C5 NYC
Dr. Cathy Eng Yelena Y. Janjigian MD
#GDUGI #greatdebatesandupdates
We’re hoping to enrich the evidence for testing all with our Bowel Cancer UK funded project sequencing germline of all GI cancer patients before treatment using ultra rapid Oxford Nanopore adaptive sequencing of 187 genes associated with hereditary cancer
bowelcanceruk.org.uk/research/our-r…
.Somedeb Ball, of Vanderbilt-Ingram Cancer Center, discusses data from the phase 3 IMerge trial of imetelstat vs placebo in low– to intermediate-risk myelodysplastic syndromes. #oncology #hematology onclive.com/view/dr-ball-o…
Next debate Great Debates & Updates is short course vs. long course neoadjuvant XRT in rectal cancer Josh Smith, MD, PhD, FACS Memorial Sloan Kettering Cancer Center vs. Jennifer Wo Mass General Cancer Center. Your thoughts? #cancer #cancer research #clincialtrials #colorectal #crcsm
Nothing like kicking off #DDW2024 with a talk about new #colorectalcancer screening tests! 💙
Thank you American Gastroenterological Association (AGA) for the opportunity to speak today in the post-grad course.
Early start but well worth it.
So excited about the next 4 days here in DC!